Evidence map›Paper›PMID 24728293›Full record

SynthesisNature genetics2014

Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31.

Unnur Styrkarsdottir, Gudmar Thorleifsson, Hafdis T Helgadottir, Nils Bomer, Sarah Metrustry, S Bierma-Zeinstra, Annelieke M Strijbosch, Evangelos Evangelou, Deborah Hart, Marian Beekman and 28 more

Open access · greenAbstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Nature genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 5 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 5 syntheses or guidelines pooled it, 155 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Exploring Talarozole as a Novel Therapeutic Approach for Osteoarthritis: Insights From Experimental Studies.Clinical medicine insights. Arthritis and musculoskeletal disorders · 2024
    Article
  14. Article
  15. Article
  16. A Functional Polymorphism Downstream of Vitamin A Regulator GeneInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Article
  19. Genetics of osteoarthritis.Osteoarthritis and cartilage · 2022
    Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 11 institutions in 5 countries.

Unnur StyrkarsdottirdeCODE Genetics/Amgen, Reykjavik, Iceland.ORCID 0000000181468278
Gudmar ThorleifssondeCODE Genetics/Amgen, Reykjavik, Iceland.
Hafdis T HelgadottirdeCODE Genetics/Amgen, Reykjavik, Iceland.
Nils BomerDepartment of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Sarah MetrustryDepartment of Twin Research, King's College London, St. Thomas' Hospital, London, UK.
S Bierma-ZeinstraDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Annelieke M StrijboschDepartment of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Evangelos Evangelou1] Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece. [2] Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
Deborah HartDepartment of Twin Research, King's College London, St. Thomas' Hospital, London, UK.
Marian Beekman1] Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. [2] Integrated Research on Developmental Determinants of Ageing and Longevity (IDEAL), Leiden, The Netherlands. [3] Genomics Initiative, sponsored by the Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.
Aslaug JonasdottirdeCODE Genetics/Amgen, Reykjavik, Iceland.
Asgeir SigurdssondeCODE Genetics/Amgen, Reykjavik, Iceland.
Finnur F EirikssonArctic Mass, Reykjavik, Iceland.
Margret Thorsteinsdottir1] Arctic Mass, Reykjavik, Iceland. [2] Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Michael L FriggedeCODE Genetics/Amgen, Reykjavik, Iceland.
Augustine KongdeCODE Genetics/Amgen, Reykjavik, Iceland.
Sigurjon A GudjonssondeCODE Genetics/Amgen, Reykjavik, Iceland.
Olafur T MagnussondeCODE Genetics/Amgen, Reykjavik, Iceland.
Gisli MassondeCODE Genetics/Amgen, Reykjavik, Iceland.
TREAT-OA Consortium
arcOGEN Consortium
Albert HofmanDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Nigel K ArdenNational Institute for Health Research (NIHR) Biomedical Research Unit, University of Oxford, Oxford, UK.
Thorvaldur Ingvarsson1] Department of Orthopedic Surgery, Akureyri Hospital, Akureyri, Iceland. [2] Institution of Health Science, University of Akureyri, Akureyri, Iceland.
Stefan LohmanderDepartment of Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden.
Margreet Kloppenburg1] Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. [2] Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Fernando Rivadeneira1] Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands. [2] Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Rob G H H NelissenDeptartment of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands.
Tim SpectorDepartment of Twin Research, King's College London, St. Thomas' Hospital, London, UK.
Andre Uitterlinden1] Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands. [2] Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
P Eline Slagboom1] Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. [2] Integrated Research on Developmental Determinants of Ageing and Longevity (IDEAL), Leiden, The Netherlands. [3] Genomics Initiative, sponsored by the Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.
Unnur Thorsteinsdottir1] deCODE Genetics/Amgen, Reykjavik, Iceland. [2] Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Ingileif Jonsdottir1] deCODE Genetics/Amgen, Reykjavik, Iceland. [2] Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Ana M Valdes1] Department of Twin Research, King's College London, St. Thomas' Hospital, London, UK. [2] Academic Rheumatology, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Ingrid Meulenbelt1] Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. [2] Genomics Initiative, sponsored by the Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.
Joyce van MeursDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Helgi Jonsson1] Faculty of Medicine, University of Iceland, Reykjavik, Iceland. [2] Department of Medicine, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Kari Stefansson1] deCODE Genetics/Amgen, Reykjavik, Iceland. [2] Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
deCODE Genetics (Iceland) · ISLeiden University Medical Center · NLErasmus MC · NLSt Thomas' Hospital · GBUniversity of Iceland · ISAkureyri Hospital · ISLund University · SENational Institute for Health Research · GBNetherlands Consortium for Healthy Ageing · NLUniversity of Ioannina · GRUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis is the most common form of arthritis and is a major cause of pain and disability in the elderly. To search for sequence variants that confer risk of osteoarthritis of the hand, we carried out a genome-wide association study (GWAS) in subjects with severe hand osteoarthritis, using variants identified through the whole-genome sequencing of 2,230 Icelanders. We found two significantly associated loci in the Icelandic discovery set: at 15q22 (frequency of 50.7%, odds ratio (OR) = 1.51, P = 3.99 × 10(-10)) in the ALDH1A2 gene and at 1p31 (frequency of 0.02%, OR = 50.6, P = 9.8 × 10(-10)). Among the carriers of the variant at 1p31 is a family with several members in whom the risk allele segregates with osteoarthritis. The variants within the ALDH1A2 gene were confirmed in replication sets from The Netherlands and the UK, yielding an overall association of OR = 1.46 and P = 1.1 × 10(-11) (rs3204689).

Indexed as

Genetic VariationAldehyde Dehydrogenase 1 FamilyBase SequenceCartilageChromosomes, Human, Pair 1Computational BiologyGene Expression ProfilingGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHandHumansIcelandMolecular Sequence DataNetherlandsOsteoarthritisAldehyde Dehydrogenase 1 FamilyALDH1A2 protein, humanRetinal Dehydrogenase

Identifiers

PMID24728293
OpenAlexW2000862295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.